Harmony Biosciences Holdings, Inc.
Harmony Biosciences Holdings, Inc. (HRMY) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
hrmy · stock forecast · 13 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 13 Wall Street analysts in the past 3 months
Buy
13 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$50.00
Consensus
$43.00
+31.7% upside
Low
$31.00
Median: $45.5 · Last Close: $32.64
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$43.00
31.7% upside
High Target
$50
53.2%
Low Target
$31
-5.0%
Current Price
$32.64
as of today
Based on analyst price targets, the HRMY stock price prediction for the next 12 months ranges from $31 to $50. The consensus HRMY price forecast of $43.00 implies 31.7% upside from the current price of $32.64.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $33.40 | ↑ 2.33% |
1-day model range: $33.28–$33.52. Peak: $33.52 (+2.33%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $41 | +26.9% |
| 2028 | $48 | +45.7% |
| 2029 | $51 | +57.5% |
| 2030 | $54 | +64.5% |
| 2031 | — | +68.6% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · HRMY · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-08 | Truist Securities | Maintains | Hold→Hold |
| 2026-02-25 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-25 | Needham | Maintains | Buy→Buy |
| 2026-02-25 | B of A Securities | Maintains | Underperform→Underperform |
| 2026-02-25 | UBS | Maintains | Neutral→Neutral |
| 2026-02-11 | UBS | Downgrade ↓ | Buy→Neutral |
| 2026-01-08 | Truist Securities | Maintains | Buy→Buy |
| 2025-12-01 | Mizuho | Maintains | Outperform→Outperform |
| 2025-11-24 | Needham | Maintains | Buy→Buy |
| 2025-11-24 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Harmony Biosciences Holdings, Inc. (HRMY) stock. Of the recent 109 rating actions, 2 were upgrades and 5 were downgrades. 13 analysts currently cover HRMY.
Analyst Recommendation Trends
HRMY analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$1.0B
↓ 19.9% YoY
Revenue Next Year
$1.1B
↑ 13.7% YoY
EPS This Year
$3.43
EPS Next Year
$4.13
↑ 20.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast HRMY EPS of $3.43 for the current fiscal year, based on estimates from 7 analysts. The HRMY revenue forecast is $1.0B for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The HRMY stock forecast is supported by two independent data sources: analyst consensus ratings from 13 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus HRMY price target is $43.00 (+31.7% upside), with an analyst consensus of Buy.
The HRMY short-term stock prediction for tomorrow is $33.40 (+2.33%). The HRMY stock price prediction for 2027 estimates an average of $41. The HRMY stock prediction for 2030 projects a range of $52–$56.
Harmony Biosciences Holdings, Inc. trades on NASDAQ under the ticker HRMY. The HRMY stock outlook for 2027 is broadly positive, supported by a Buy consensus among 69% of covering analysts.
Frequently asked questions
HRMY forecast · 8 questionsAccording to 13 Wall Street analysts, the average 12-month HRMY price target is $43.00, with a high forecast of $50.00 and a low of $31.00. The median price target is shown in the chart above when available. This implies +31.7% potential upside from the current price of $32.64.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.